Cargando…

Biotechnology entrepreneurship : leading, managing and commercializing innovative technologies /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Shimasaki, Craig D. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London, United Kingdom : Academic Press, [2020]
Edición:Second edition.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_on1155400074
003 OCoLC
005 20231120010453.0
006 m o d
007 cr cnu||||||||
008 200527s2020 enka ob 001 0 eng d
040 |a YDX  |b eng  |e rda  |e pn  |c YDX  |d OPELS  |d N$T  |d TXM  |d OCLCF  |d ORU  |d UCW  |d OCLCQ  |d OCLCO  |d K6U  |d OCLCQ  |d OCLCO 
019 |a 1175761732 
020 |a 9780128155868  |q (electronic bk.) 
020 |a 0128155868  |q (electronic bk.) 
020 |z 012815585X  |q (hardcover) 
020 |z 9780128155851  |q (hardcover) 
035 |a (OCoLC)1155400074  |z (OCoLC)1175761732 
050 4 |a HD9999.B442 
082 0 4 |a 338.476606  |2 23 
245 0 0 |a Biotechnology entrepreneurship :  |b leading, managing and commercializing innovative technologies /  |c edited by Craig Shimasaki. 
250 |a Second edition. 
264 1 |a London, United Kingdom :  |b Academic Press,  |c [2020] 
264 4 |c �2020 
300 |a 1 online resource (xxxiii, 648 pages) :  |b color illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Online resource; title from digital title page (ScienceDirect, viewed May 3, 2021). 
504 |a Includes bibliographical references and index. 
505 0 0 |g Section I.  |t Understanding biotechnology entrepreneurship  |t -- What is biotechnology entrepreneurship? /  |r Craig Shimasaki --  |t A biotechnology entrepreneur's legacy - Henri A. Termeer's story and his advice to entrepreneurs /  |r Henri A. Termeer --  |t A biotechnology entrepreneur's story: from start-up to international contract development and manufacturing organization /  |r Magda Marquet and Fra�nois Fer�r --  |t Seven characteristics of successful biotechnology leaders /  |r Lynn Johnson Langer --  |g Section II.  |t Overview of the biotechnology industry --  |t Unleashing the promise of biotechnology to help heal, fuel, and feed the world /  |r James C. Greenwood --  |t Five essential elements and regional influences required to grow and expand a biotechnology cluster or hub /  |r Craig Shimasaki --  |g Section III.  |t The human capital component --  |t Building, managing, and motivating great teams /  |r Arthur A. Boni, Gergana Todorova and Laurie R. Weingart --  |t Building human relationship networks /  |r Tom D. Walker --  |t Mentorship: Why you need a team of mentors to be successful /  |r Craig Shimasaki --  |g Section IV.  |t The innovative technology component --  |t Understanding biotechnology product sectors /  |r Craig Shimasaki --  |t Technology opportunities: evaluating the idea /  |r Craig Shimasaki --  |t Understanding biotechnology business models and managing risk /  |r Craig Shimasaki --  |t Directing your technology toward a market problem: What you need to know before using the business model canvas? /  |r Craig Shimasaki --  |g Section V.  |t The emerging biotechnology enterprise --  |t Company formation, ownership structure, and securities issues /  |r Craig C. Bradley --  |t Licensing the technology: Biotechnology commercialization strategies using university and federal labs /  |r Steven M. Ferguson and Uma S. Kaundinya --  |t Intellectual property protection strategies for biotechnology innovations /  |r Gerry J. Elman and Jay Z. Zhang --  |g Section VI.  |t The financial capital component --  |t Sources of capital and investor motivations /  |r Craig Shimasaki --  |t How investors really make decisions: What entrepreneurs need to know when raising money /  |r Konstantin S. Kostov --  |t Securing angel capital and understanding how angel networks operate /  |r Robert J. Calcaterra --  |t Understanding and securing venture capital: An entrepreneur's perspective /  |r Craig Shimasaki --  |t Financial ramifications of funding a biotechnology venture: What you need to know about valuation and term sheets /  |r Stephen M. Sammut --  |t Your business plan and presentation: Articulating your journey to commercialization /  |r Lowell W. Busenitz --  |t Investor presentations: What do you need in an investor pitch deck? /  |r Craig Shimasaki --  |g Section VII.  |t Biotechnology product development --  |t Therapeutic drug development and human clinical trials /  |r Donald R. Kirsch --  |t Integrating diagnostic products into the drug development workflow: Applications for companion diagnostics /  |r John F. Beeler --  |t The development and commercialization of medical devices /  |r Mark Byrne --  |t Commercialization and applications of agricultural biotechnology /  |r Neal Gutterson --  |t Artificial intelligence: Emerging applications in biotechnology and pharma /  |r David Sahner and David C. Spellmeyer --  |t Artificial intelligence in biotechnology: A framework for commercialization /  |r Robert E. Wanerman, Gail H. Javitt and Alaap B. Shah --  |t Regulatory approval and compliances for biotechnology products /  |r Norman W. Baylor and Donna-Bea Tillman --  |t The biomanufacturing of biotechnology products /  |r John Conner, Don Wuchterl, ... Chris Allen --  |t Biotechnology products and their customers: Developing a successful market strategy /  |r Craig Shimasaki --  |g Section VIII.  |t Biotechnology market development --  |t Biotechnology product coverage, coding, and reimbursement strategies /  |r Robert E. Wanerman and Susan Garfield --  |t Getting the word out: Public relations strategies to support biotechnology business goals /  |r Joan E. Kureczka --  |g Section IX.  |t The latter-stage biotechnology company --  |t Company growth stages and the value of corporate culture /  |r Craig Shimasaki --  |t Biotechnology business development: The art of the deal /  |r Jack M. Anthony, Philip Haworth and Gayle M. Mills --  |t Biotech-pharma collaboration-A strategic tool: Case study of Centocor /  |r Lara V. Marks --  |t The emergence and transformation of China in biotechnology /  |r Jimmy Zhimin Zhang --  |t Ethical considerations for biotechnology leaders /  |r Gladys B. White --  |t Diverse career opportunities in the biotechnology and life sciences industry /  |r Toby Freedman --  |t Common biotechnology entrepreneur mistakes and how to avoid them /  |r Craig Shimasaki --  |t Summary. /  |r Toby Freedman. 
650 0 |a Biotechnology industries. 
650 0 |a Entrepreneurship. 
650 2 |a Entrepreneurship  |0 (DNLM)D016520 
650 6 |a Bio-industries.  |0 (CaQQLa)201-0136258 
650 6 |a Entrepreneuriat.  |0 (CaQQLa)201-0030347 
650 7 |a entrepreneurs.  |2 aat  |0 (CStmoGRI)aat300025222 
650 7 |a Biotechnology industries  |2 fast  |0 (OCoLC)fst00832791 
650 7 |a Entrepreneurship  |2 fast  |0 (OCoLC)fst00912787 
700 1 |a Shimasaki, Craig D.,  |e editor. 
776 0 8 |i Print version:  |z 012815585X  |z 9780128155851  |w (OCoLC)1089577317 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780128155851  |z Texto completo